Christine Espenilla, APRN
Primary Care · Las Vegas, NVNPI 1851052484
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $1,165 of the $1,692 with a category attached, or 68.8%. Kerecis Limited accounts for 83.5% of it on its own, with 6 other manufacturers making up the rest. Reporting peaked in 2022 at $1,363 and has fallen 87.4% since, to $172 in 2024.
Across 13 payments — averaging $130.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Kerecis Limited$1K
- KCI USA, Inc.$124
- Paratek Pharmaceuticals, Inc.$45
- Smith+Nephew$34
- Solventum Corporation$28
- Hartmann USA, Inc.$24
- plus $24 from 1 others
What the payments were for
- Travel & lodging$1,16569%
- Food & beverage$52731%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Kerecis Limited | 3 | $1,413 |
| KCI USA, Inc. | 2 | $124 |
| Paratek Pharmaceuticals, Inc. | 3 | $45 |
| Smith+Nephew | 2 | $34 |
| Solventum Corporation | 1 | $28 |
| Hartmann USA, Inc. | 1 | $24 |
| AbbVie | 1 | $24 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Kerecis Omega3 Marigen$4,059
- Kerecis Omega3 SurgiClose$1,699
- Kerecis Omega3 GraftGuide$1,308
How this compares
$1,692 in reported general payments places this provider in the 85th percentile of 81 primary care providers in Nevada.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Triamcinolone Acetonide | 37 | $1,752 |
| Clobetasol Propionate | 16 | $1,250 |
| Nystatin-TriamcinoloneNystatin/Triamcinolone Acet | 24 | $956 |
| KlayestaNystatin | 22 | $945 |
| NystopNystatin | 15 | $868 |
| Hydrocortisone | 22 | $793 |
| Mupirocin | 25 | $499 |
| Nystatin | 17 | $476 |
| Silver Sulfadiazine | 12 | $381 |
| Gentamicin Sulfate | 11 | $294 |
| Ammonium Lactate | 17 | $237 |
| SsdSilver Sulfadiazine | 13 | $197 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 12 | $137 |
| Levofloxacin | 16 | $103 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 19 | $50 |
Paid to pharmacies, not to this prescriber.
Other primary care in Las Vegas
- Jennifer CribbLas Vegas$7K
- Ruel MarianoLas Vegas$4K
- George Gabriel ToldnessLas Vegas$4K
- Jona SteadLas Vegas$3K
- Mario LuglioLas Vegas$3K
- Jocybel ItorralbaLas Vegas$3K
- Jerifaye FloresLas Vegas$2K
- Sneha ThomasLas Vegas$2K
- Yoslady MoralesLas Vegas$2K
- Tina SajadiLas Vegas$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.